Acquisition by Scott Drake of 21021 shares of Farmer Bros subject to Rule 16b-3

VRAYDelisted Stock  USD 0.04  0  5.67%   
Slightly above 62% of ViewRay's investor base is looking to short. The analysis of current outlook of investing in ViewRay suggests that many traders are alarmed regarding ViewRay's prospects. ViewRay's investing sentiment can be driven by a variety of factors including economic data, ViewRay's earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Farmer Bros Co Officer Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Farmer insider trading alert for acquisition of common stock by Scott Drake, Officer: Chief Financial Officer, on 30th of March 2024. This event was filed by Farmer Bros Co with SEC on 2021-09-13. Statement of changes in beneficial ownership - SEC Form 4

ViewRay Fundamental Analysis

We analyze ViewRay's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViewRay using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViewRay based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Employees

Number Of Employees Comparative Analysis

ViewRay is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.

ViewRay Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ViewRay stock to make a market-neutral strategy. Peer analysis of ViewRay could also be used in its relative valuation, which is a method of valuing ViewRay by comparing valuation metrics with similar companies.

Peers

ViewRay Related Equities

BBLGBone Biologics   5.56   
0%
38.0%
ESTAEstablishment Labs   3.93   
0%
27.0%
HSCSHeart Test   1.06   
0%
7.0%
DCTHDelcath Systems   0.08   
1.0%
0%
INGNInogen   0.23   
1.0%
0%
AXGNAxogen   0.42   
2.0%
0%
SGHTSight Sciences   1.11   
7.0%
0%
AORTArtivion   1.16   
8.0%
0%
AVNSAvanos Medical   1.49   
10.0%
0%
ATECAlphatec Holdings   1.50   
10.0%
0%
OFIXOrthofix Medical   1.68   
11.0%
0%
VVOSVivos Therapeutics   2.31   
16.0%
0%
ANIKAnika Therapeutics   2.46   
17.0%
0%
CVRXCVRx   3.30   
23.0%
0%
NPCENeuropace   5.99   
41.0%
0%
TIVCTivic Health   14.29   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in ViewRay Stock

If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities